Home > Insider Trading > Filing (0001104659-24-064004)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1814114	Orchestra Biomed Holdings Inc.	OBIO	()	4/A

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1292834	P David Hochman	C/O Orchestra Biomed Holdings, Inc. 150 Union Square Drive New Hope PA 18938	See Remarks	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001 Per Share ("Common Stock")	Acquisiton	2024-05-16	2,000	$4.75	329,502	No	4	P	Indirect	By the DPH 2008 Trust
Common Stock	Acquisiton	2024-05-17	3,000	$5.15	332,502	No	4	P	Indirect	By the DPH 2008 Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By the DPH 2008 Trust
No	4	P	Indirect	By the DPH 2008 Trust

Footnotes

On May 20, 2024, the Reporting Person filed a Form 4 which inadvertently misstated the transaction codes in Column 3 of Table I. This amendment is filed solely to correct the transaction codes in Column 3 of Table I to "P". The remainder of the information in the original filing is not restated in this amendment, and no other amendment is made to the original filing.
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.74 to $4.78, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.92 to $5.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.